Cardiff Oncology Inc. Soared
Fri, Mar 01, 2024 at 07:12 PM
Cardiff Oncology Inc. (CRDF:NASDAQ) shot up at $2.91, representing a gain of 64.9%. On Fri, Mar 01, 2024, CRDF:NASDAQ hit a New 2-Week High of $2.91. The stock appeared on our News Catalysts scanner on Fri, Mar 01, 2024 at 10:30 AM in the 'EARNINGS' category. From Fri, Feb 16, 2024, the stock recorded 55.56% Up Days and 50.00% Green Days
About Cardiff Oncology Inc. (CRDF:NASDAQ)
Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic...
Top 10 Gainers:
- Unico American Corporation (UNAM:NASDAQ), 203.03%
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
- Mmtec, Inc. (MTC:NASDAQ), 96.92%
- Cardiff Oncology Inc. (CRDF:NASDAQ), 64.87%
- Adial Pharmaceuticals, Inc. (ADIL:NASDAQ), 59.8%
- The RealReal, Inc. (REAL:NASDAQ), 55.93%
- Roma Green Finance Limited (ROMA:NASDAQ), 51.11%
- Jaguar Health, Inc. (JAGX:NASDAQ), 50%
- JanOne Inc. (JAN:NASDAQ), 46.33%
- Xponential Fitness Inc. Class A (XPOF:NYSE), 39.38%